1. Home
  2. DTI vs IFRX Comparison

DTI vs IFRX Comparison

Compare DTI & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Drilling Tools International Corporation

DTI

Drilling Tools International Corporation

HOLD

Current Price

$3.45

Market Cap

76.7M

Sector

Industrials

ML Signal

HOLD

Logo InflaRx N.V.

IFRX

InflaRx N.V.

HOLD

Current Price

$1.03

Market Cap

81.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTI
IFRX
Founded
1984
2007
Country
United States
Germany
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.7M
81.3M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
DTI
IFRX
Price
$3.45
$1.03
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.50
AVG Volume (30 Days)
189.5K
647.2K
Earning Date
11-06-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$160,964,000.00
$73,729.00
Revenue This Year
$3.41
N/A
Revenue Next Year
$1.30
$1,054.36
P/E Ratio
N/A
N/A
Revenue Growth
7.46
N/A
52 Week Low
$1.43
$0.71
52 Week High
$3.82
$2.77

Technical Indicators

Market Signals
Indicator
DTI
IFRX
Relative Strength Index (RSI) 66.34 45.22
Support Level $2.45 $1.00
Resistance Level $3.42 $1.10
Average True Range (ATR) 0.30 0.08
MACD 0.07 -0.00
Stochastic Oscillator 99.15 15.22

Price Performance

Historical Comparison
DTI
IFRX

About DTI Drilling Tools International Corporation

Drilling Tools International Corp manufactures, rents, inspects, and refurbishes downhole drilling tools primarily to companies in the oil and natural gas industry for bottom hole assemblies used in onshore and offshore horizontal and directional drilling. The company's United States operations have locations in Texas, California, Louisiana, Oklahoma, Pennsylvania, North Dakota, New Mexico, Utah, and Wyoming. The company's single segment derives revenues from customers by providing oilfield equipment and services to operators in the oil and natural gas sectors.

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

Share on Social Networks: